Business Description
Kobo Biotech Ltd
ISIN : INE881A01015
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -1.78 | |||||
Debt-to-Equity | -1.07 | |||||
Debt-to-EBITDA | -99.59 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -26.7 | |||||
3-Year EPS without NRI Growth Rate | 35.8 | |||||
3-Year FCF Growth Rate | -60.8 | |||||
3-Year Book Growth Rate | -13.3 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.74 | |||||
9-Day RSI | 44 | |||||
14-Day RSI | 45.55 | |||||
6-1 Month Momentum % | 68.98 | |||||
12-1 Month Momentum % | 72.5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.23 | |||||
Quick Ratio | 0.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 7.83 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -7.26 | |||||
ROIC % | -3.35 | |||||
ROC (Joel Greenblatt) % | -14.54 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 12.02 | |||||
Price-to-Free-Cash-Flow | 11.83 | |||||
Price-to-Operating-Cash-Flow | 11.83 | |||||
EV-to-EBIT | -27.2 | |||||
EV-to-EBITDA | -105.99 | |||||
EV-to-FCF | 170.97 | |||||
Price-to-Projected-FCF | 0.09 | |||||
Earnings Yield (Greenblatt) % | -3.67 | |||||
FCF Yield % | 9.09 |